NCT04172168 is a clinical trial of Heart rupture in Acute Myocardial Infarction, sponsored by Xiamen Cardiovascular Hospital, Xiamen University.

Who is sponsoring NCT04172168?

NCT04172168 is sponsored by Xiamen Cardiovascular Hospital, Xiamen University.

What drugs are being tested in NCT04172168?

Interventions in NCT04172168: Heart rupture.

What condition does NCT04172168 study?

NCT04172168 studies Acute Myocardial Infarction.

Is NCT04172168 still recruiting?

NCT04172168 is currently status unknown. Last updated 1 April 2021.

Last reviewed 2021-04-01 · How we verify

NCT04172168

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction (LVFR-AMI)

Status unknown Last updated 1 April 2021

What this trial tests

trial testing Heart rupture in Acute Myocardial Infarction in 17,568 participants. Status unknown.

Timeline

1 January 2011

Primary endpoint
31 December 2019

31 March 2021

Quick facts

Lead sponsor	Xiamen Cardiovascular Hospital, Xiamen University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	17,568
Start date	1 January 2011
Primary completion	31 December 2019
Estimated completion	31 March 2021
Sites	1 location across China

Drugs / interventions tested

Heart rupture

Conditions studied

Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →

Sponsor

Xiamen Cardiovascular Hospital, Xiamen University

Who can join

18 and older, any sex, with Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Left Ventricular Free-wall Ruptrue (LVFR) is a serious complication caused high mortality.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Manifestation of Cardiac Rupture in Patients with ST-Segment Elevation Myocardial Infarction: Early Versus Late Primary Percutaneous Coronary Intervention.
Bi X, Wang B, Tse G, Dai C, et al · · 2022 · cited 2× · PMID 36199564 · DOI 10.5334/gh.1155

Verify or expand the search:

Other trials of Heart rupture

Trials testing the same drug.

NCT04104269 — Mechanical Structure Complications After Acute Myocardial Infarction · unknown

Other recruiting trials for Acute Myocardial Infarction

Currently open trials in the same condition.

NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
NCT06947135 — Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury · NA · recruiting
NCT06515730 — Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction · Phase 4 · recruiting
NCT07522164 — Acute Myocardial Infarction Clinical Cohort · active not recruiting

Other Xiamen Cardiovascular Hospital, Xiamen University trials

Trials by the same sponsor.

NCT07055919 — Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER). · NA · recruiting
NCT06532838 — Optimized Strategies for Malperfusion Syndrome · NA · not yet recruiting
NCT05925335 — The China Mviv Registry · NA · unknown
NCT05497141 — Dawneo Neoblazar® Transcatheter Tricuspid Valve Edge-to Edge Repair System Pivotal Clinical Trial in Patients With Sever · NA · unknown
NCT04918030 — STaged Interventional Strategies for Acute ST-seGment Elevation Myocardial Infarction Patient With Multi-vessel Disease（ · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04172168 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xiamen Cardiovascular Hospital, Xiamen University
Last refreshed: 1 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04172168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing